1 completed, 1 terminated. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow MedDerm Associates: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Broadlumab vs Placebo and Ustekinumab 210mg Brodalumab, 140mg Brodalumab, Ustekinumab - Psoriasis | Phase 3 | Terminated | MedDerm Associates | 15 | 2012-08-01 | 2016-06-01 |
| Comparison Study of Topical Acne Regimens Acne Free, Proactiv - Acne | Phase 4 | Completed | MedDerm Associates | 128 | 2006-12-01 | 2014-06-24 |
Acne Vulgaris (1) · Psoriasis (1)
Ustekinumab (1) · brodalumab (1)
United States (2)